Information for "Singlefraction HDR brachytherapy as monotherapy within reduced and more advanced risk cancer of prostate Benefits through two clinical trials together with as well as lacking an MRIguided enhance"

From EECH Central
Jump to: navigation, search

Basic information

Display titleSinglefraction HDR brachytherapy as monotherapy within reduced and more advanced risk cancer of prostate Benefits through two clinical trials together with as well as lacking an MRIguided enhance
Default sort keySinglefraction HDR brachytherapy as monotherapy within reduced and more advanced risk cancer of prostate Benefits through two clinical trials together with as well as lacking an MRIguided enhance
Page length (in bytes)3,337
Page ID1415182
Page content languageEnglish (en)
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)

Edit history

Page creatorClausflesh1 (Talk | contribs)
Date of page creation10:07, 28 April 2024
Latest editorClausflesh1 (Talk | contribs)
Date of latest edit10:07, 28 April 2024
Total number of edits1
Total number of distinct authors1
Recent number of edits (within past 90 days)1
Recent number of distinct authors1